Machine Learning Approach to Identify Stroke Within 4.5 Hours.

Journal: Stroke
Published Date:

Abstract

Background and Purpose- We aimed to investigate the ability of machine learning (ML) techniques analyzing diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging to identify patients within the recommended time window for thrombolysis. Methods- We analyzed DWI and FLAIR images of consecutive patients with acute ischemic stroke within 24 hours of clear symptom onset by applying automatic image processing approaches. These processes included infarct segmentation, DWI, and FLAIR imaging registration and image feature extraction. A total of 89 vector features from each image sequence were captured and used in the ML. Three ML models were developed to estimate stroke onset time for binary classification (≤4.5 hours): logistic regression, support vector machine, and random forest. To evaluate the performance of ML models, the sensitivity and specificity for identifying patients within 4.5 hours were compared with the sensitivity and specificity of human readings of DWI-FLAIR mismatch. Results- Data from a total of 355 patients were analyzed. DWI-FLAIR mismatch from human readings identified patients within 4.5 hours of symptom onset with 48.5% sensitivity and 91.3% specificity. ML algorithms had significantly greater sensitivities than human readers (75.8% for logistic regression, =0.020; 72.7% for support vector machine, =0.033; 75.8% for random forest, =0.013) in detecting patients within 4.5 hours, but their specificities were comparable (82.6% for logistic regression, =0.157; 82.6% for support vector machine, =0.157; 82.6% for random forest, =0.157). Conclusions- ML algorithms using multiple magnetic resonance imaging features were feasible even more sensitive than human readings in identifying patients with stroke within the time window for acute thrombolysis.

Authors

  • Hyunna Lee
    Department of Radiology, Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea.
  • Eun-Jae Lee
    Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (E.-J.L., H.-B.L., S.U.K., J.S.K., D.-W.K.).
  • Sungwon Ham
    Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (S.H.).
  • Han-Bin Lee
    Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (E.-J.L., H.-B.L., S.U.K., J.S.K., D.-W.K.).
  • Ji Sung Lee
    Clinical Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (J.S.L.).
  • Sun U Kwon
    Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (E.-J.L., H.-B.L., S.U.K., J.S.K., D.-W.K.).
  • Jong S Kim
    Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (E.-J.L., H.-B.L., S.U.K., J.S.K., D.-W.K.).
  • Namkug Kim
    Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Dong-Wha Kang
    Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (E.-J.L., H.-B.L., S.U.K., J.S.K., D.-W.K.).